CAP BUSINESS CENTER, HERSTAL, C9
Material disclosure
Reports Q1-2026 Results
2026 Warrants Terms and Conditions
Announces Fourth Quarter and Full-Year 2025 Financial Results
Acquires Exosome Diagnostics
Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms
Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Prospectus filed pursuant to Rule 424(b)(5)
No filings found
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload